Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 59.71M
March 31, 2026 59.66M
December 31, 2025 59.42M
September 30, 2025 59.29M
June 30, 2025 59.22M
March 31, 2025 59.08M
December 31, 2024 58.74M
September 30, 2024 58.27M
June 30, 2024 58.19M
March 31, 2024 58.10M
December 31, 2023 57.86M
September 30, 2023 57.75M
June 30, 2023 57.63M
March 31, 2023 57.47M
December 31, 2022 57.31M
September 30, 2022 56.92M
June 30, 2022 56.74M
March 31, 2022 56.66M
December 31, 2021 56.57M
September 30, 2021 56.45M
June 30, 2021 56.22M
March 31, 2021 55.93M
December 31, 2020 55.62M
September 30, 2020 55.54M
June 30, 2020 55.48M
Date Value
March 31, 2020 55.34M
December 31, 2019 55.21M
September 30, 2019 55.21M
June 30, 2019 55.08M
March 31, 2019 55.00M
December 31, 2018 54.89M
September 30, 2018 54.80M
June 30, 2018 50.64M
March 31, 2018 50.35M
December 31, 2017 50.25M
September 30, 2017 50.19M
June 30, 2017 50.09M
March 31, 2017 49.89M
December 31, 2016 44.64M
September 30, 2016 44.59M
June 30, 2016 44.32M
March 31, 2016 44.30M
December 31, 2015 44.27M
September 30, 2015 44.20M
June 30, 2015 44.12M
March 31, 2015 44.00M
December 31, 2014 43.61M
September 30, 2014 43.24M
June 30, 2014 43.22M
March 31, 2014 42.96M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Globus Medical, Inc. 134.25M
Baxter International, Inc. 517.00M
DexCom, Inc. 377.40M
Haemonetics Corp. 45.47M
ICU Medical, Inc. 25.01M